Lv1
50 积分 2026-04-27 加入
GLP-1-based combination strategies for weight loss: Multi-target agents and combination therapies
8小时前
已完结
Authors’ Reply: SGLT2 Inhibitors vs GLP-1 Receptor Agonists Type 2 Diabetes, the Kidney Conundrum
2个月前
已关闭
Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity
2个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
2个月前
已完结
皖公网安备34019202002308
